{"F": {"ts_code": "US.GRFS", "name": "基立福", "mkt": "US", "ccy": "美元", "sw1": "一般药品制造商", "sw2": "一般药品制造商", "sw3": "", "ind": "一般药品制造商", "fin_source": "futu", "market": "NASDAQ", "list_date": null, "is_fin": false, "roles": {"fin": false, "commodity": false, "precious": false, "regulated": false, "hard": false, "growth": false}, "province": null, "main_business": "", "introduction": "", "close": 7.8, "pe_ttm": 10.169, "pb": 0.823, "dv_ttm": 3.56, "total_mv": 530852.79546, "trade_date": "20260904", "years": ["最近年报"], "multi_year": false, "period": "最近年报", "gm_series": [38.0], "rev_series": [88.4], "np_series": [5.9], "roe_series": [7.2], "rev_ttm": 88.4, "np_ttm": 5.2, "ocf_ttm": 12.7, "fcf_ttm": null, "fcf_yield": null, "ocf_yield": 23.9, "gm_median": 38.0, "gm_std": null, "gm_stab": null, "gm_chg_2022": null, "npm_median": 6.6, "roe_median": 7.2, "commodity": false, "hard_ratio": 16.6, "fix_assets": 37.8, "hard_note": "PP&E 毛额 × 0.5 近似净额", "goodwill_ratio": null, "pb_calc": null, "capex_dep": null, "interest_debt": null, "debt_ebitda": null, "ebitda": 19.3, "debt_ratio": 61.4, "debt_mv": null, "payout": 36.0, "div_years": 1, "rev_cagr3": null, "np_cagr3": null, "rev_yoy": 17.8, "np_yoy": 165.0, "np_vol": null, "loss_years": 0, "far_share": 51.0, "earn_yield": 9.8, "consensus_n": 0, "fwd_pe": null, "fwd_pe2": null, "fwd_g1": null, "fwd_g2": null, "peg": null, "consensus_disp": null, "mainbz": [], "ret_prev_year": null, "ret_prev2_year": null, "ret_pivot": null, "prev_year": "", "prev2_year": "", "ret_ytd": -15.5, "ret_20": -1.8, "ret_60": 8.0, "ret_120": -1.8, "ret_250": -21.8, "mdd_250": null, "vol_250": null, "pos_52w": 77.3, "eps": 0.686}, "S": {"duration": 22, "pricing": 51, "hard": 27, "bondness": 47}, "label": "中性", "tags": [], "text": {"像什么": ["PE 10.2 倍、股息率 3.6%、毛利率最新年报 38.0%、固定资产占比 17%、资产负债率 61%:四轴都不突出。"], "为什么(不)算钱的替代品": "只占定价权一条(毛利率 38.0%),硬资产占比 17%。分子能跟上通胀,但没有重置成本对冲;按'定价权·品牌'看,不按硬资产看。", "加息期怎么走": "按行业与估值常规看,没有明确的利率方向性。", "四问": [["当前 FCF 能覆盖多少市值?", "经营现金流/市值 23.9%(futu 无资本开支,FCF 按经营现金流 × 0.7 近似)。覆盖高。"], ["能否每年提价而不掉量?", "毛利率最新年报 38.0%。能。"], ["资产重置成本随通胀涨吗?", "固定资产占总资产 17%。有一些。"], ["估值里多少来自 5 年后的故事?", "按 PE 10.2 倍 粗算,约 51%(1 − 5/PE)。中等。"]], "价格行为": "近一年 -22%,现价在 52 周高点的 77%;近 20 / 60 / 120 日 -2% / 8% / -2%。", "行业对照": ["同富途行业「一般药品制造商」21 家中位:PE 24.4 / 股息率 2.1% / 毛利率 72.2% / 固定资产占比 10% / 分红率 56%。", "基立福:PE 比行业中位低 14.2倍;股息率 比行业中位高 1.5个百分点;毛利率 比行业中位低 34.2个百分点;固定资产占比 比行业中位高 6.3个百分点。"]}}